Date Fruit Extract / GSH Cancer Research Results

DFE, Date Fruit Extract: Click to Expand ⟱
Features:
Dates (the fruit of Phoenix dactylifera) have been increasingly studied for their potential anticancer and cancer-preventive properties, mainly due to their rich phytochemical content and strong antioxidant activity.
Dates contain a broad spectrum of bioactive compounds linked to cancer prevention:
-Phenolic acids – e.g., ferulic acid, gallic acid, caffeic acid, and p-coumaric acid
-Flavonoids – e.g., quercetin, luteolin, apigenin
-Carotenoids – e.g., β-carotene, lutein
-Tannins, saponins, and sterols
-Dietary fiber and polysaccharides
These compounds have antioxidant, anti-inflammatory, and antiproliferative effects.

Date fiber and polyphenols foster beneficial gut bacteria (e.g., Bifidobacterium, Lactobacillus) that produce short-chain fatty acids (SCFAs), which protect the colon and may lower colon cancer risk.

Rank Pathway / Axis Cancer / Tumor Context Normal Tissue Context TSF Primary Effect Notes / Interpretation
1 Nrf2 / ARE antioxidant response Context-dependent modulation Nrf2 ↑; antioxidant enzymes ↑ R, G Redox buffering Polyphenol-driven antioxidant response is the dominant mechanistic theme in non-malignant systems.
2 ROS / oxidative stress modulation ROS ↓ (generally); pro-oxidant effects not dominant Oxidative stress ↓ P, R Antioxidant effect Most studies describe antioxidant protection rather than tumor-selective ROS elevation.
3 NF-κB inflammatory signaling NF-κB ↓ (reported in limited models) Inflammation tone ↓ R, G Anti-inflammatory modulation Observed in inflammatory and oxidative injury systems; tumor-specific evidence is limited.
4 Intrinsic apoptosis (mitochondrial; limited data) Apoptosis ↑ (reported in some in-vitro studies) ↔ G Conditional cytotoxicity Cytotoxic effects generally mild and concentration-dependent; not comparable to strong pro-oxidants.
5 Cell-cycle arrest Cell-cycle modulation ↑ (limited evidence) ↔ G Cytostasis (weak) Evidence exists but is inconsistent and often extract-dependent.
6 PI3K → AKT signaling Limited data; possible ↓ (reported in some systems) ↔ R, G Survival pathway modulation Not a consistently demonstrated primary mechanism.
7 Angiogenesis signaling (VEGF) Limited data; possible ↓ ↔ G Potential anti-angiogenic effect Evidence sparse compared to stronger polyphenols like gallic or caffeic acid.
8 Invasion / metastasis (MMPs) Limited evidence ↔ G Uncertain tumor relevance Not well characterized mechanistically in oncology models.
9 Metabolic modulation Indirect via anti-inflammatory and antioxidant tone Metabolic support ↑ R, G Systemic metabolic effect Better supported in cardiometabolic contexts than direct anticancer contexts.
10 Extract variability / compositional heterogeneity Activity varies by cultivar, processing, solvent — — Translation constraint Whole fruit extracts differ significantly in phenolic profile and potency.

Time-Scale Flag (TSF): P / R / G

  • P: 0–30 min (rapid antioxidant interactions)
  • R: 30 min–3 hr (acute transcriptional shifts)
  • G: >3 hr (gene-regulatory and phenotype-level outcomes)
GSH, Glutathione: Click to Expand ⟱
Source:
Type:
Glutathione (GSH) is a thiol antioxidant that scavenges reactive oxygen species (ROS), resulting in the formation of oxidized glutathione (GSSG). Decreased amounts of GSH and a decreased GSH/GSSG ratio in tissues are biomarkers of oxidative stress.
Glutathione is a powerful antioxidant found in every cell of the body, composed of three amino acids: cysteine, glutamine, and glycine. It plays a crucial role in protecting cells from oxidative stress, detoxifying harmful substances, and supporting the immune system.
cancer cells can have elevated levels of glutathione, which may help them survive in the oxidative environment created by the immune response and chemotherapy. This can make cancer cells more resistant to treatment.
While glutathione can be obtained from certain foods (like fruits, vegetables, and meats), its absorption from supplements is debated. Some people take N-acetylcysteine (NAC) or other precursors to boost glutathione levels, but the effects on cancer prevention or treatment are still being studied.
Depleting glutathione (GSH) to raise reactive oxygen species (ROS) is a strategy that has been explored in cancer research and therapy.
Many cancer cells have altered redox states and may rely on GSH to survive. Increasing ROS levels can induce stress in these cells, potentially leading to cell death.
Certain drugs and compounds can deplete GSH levels. For example, agents like buthionine sulfoximine (BSO) inhibit the synthesis of GSH, leading to its depletion.
Cancer cells tend to exhibit higher levels of intracellular GSH, possibly as an adaptive response to a higher metabolism and thus higher steady-state levels of reactive oxygen species (ROS).

"...intracellular glutathione (GSH) exhibits an astounding antioxidant activity in scavenging reactive oxygen species (ROS)..."
"Cancer cells have a high level of GSH compared to normal cells."
"...cancer cells are affluent with high antioxidant levels, especially with GSH, whose appearance at an elevated concentration of ∼10 mM (10 times less in normal cells) detoxifies the cancer cells." "Therefore, GSH depletion can be assumed to be the key strategy to amplify the oxidative stress in cancer cells, enhancing the destruction of cancer cells by fruitful cancer therapy."

The loss of GSH is broadly known to be directly related to the apoptosis progression.
Scientific Papers found: Click to Expand⟱
4445- SeNPs,  DFE,    A comparative study on the hepatoprotective effect of selenium-nanoparticles and dates flesh extract on carbon tetrachloride induced liver damage in albino rats
- in-vivo, LiverDam, NA
*hepatoP↑, *antiOx↑, *AntiCan↑, *BioAv↑, *toxicity↓, *ROS↓, *MDA↓, *ALAT↓, *Albumin↑, *GSH↑, *SOD↑, *RenoP↑,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Total Targets: 0

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress ⓘ

antiOx↑, 1,   GSH↑, 1,   MDA↓, 1,   ROS↓, 1,   SOD↑, 1,  

Core Metabolism/Glycolysis ⓘ

ALAT↓, 1,  

Drug Metabolism & Resistance ⓘ

BioAv↑, 1,  

Clinical Biomarkers ⓘ

ALAT↓, 1,   Albumin↑, 1,  

Functional Outcomes ⓘ

AntiCan↑, 1,   hepatoP↑, 1,   RenoP↑, 1,   toxicity↓, 1,  
Total Targets: 13

Scientific Paper Hit Count for: GSH, Glutathione
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:371  Target#:137  State#:%  Dir#:2
  wNotes=0  sortOrder:rid,rpid

 

Home Page